Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Hodgkin's Disease and Chemotherapy Before 40 Years

NCT06116929

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Centre Hospitalier Artois Ternois Arras, France

Hôpital Claude Huriez Lille, France

Hôpital Saint-Philibert Lomme, France

Hôpital Victor Provo Roubaix, France

View Trial Details

Not Yet Recruiting

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

NCT06255704

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hematology Department of ShanXi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not Yet Recruiting

Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma

NCT05627115

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

NCT06142188

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL

NCT06062641

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Ruijin Hospital Shanghai, Shanhai, China

View Trial Details

Not Yet Recruiting

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

NCT06097455

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHU Santiago de Compostela Santiago de Compostela, A Coruña, Spain

Hospital Clínic Barcelona Barcelona, Spain

H. Ramon y Cajal Madrid, Spain

H.U. Virgen de la Arrixaca Murcia, Spain

View Trial Details

Not Yet Recruiting

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT05923502

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

NCT06049472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

NCT06049485

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

NCT05990985

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Bethune Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions